Skip to main content
SURG
NASDAQ Technology

Secures $500K in Convertible Debt, Part of $2.65M Series, Amidst Financial Distress

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$0.402
Mkt Cap
$10.102M
52W Low
$0.4
52W High
$3.45
52W Position info
0.6% above low
Off High info
88% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

SURG is trading near its 52-week low of $0.4 (0.6% above the low).

Summary

SurgePays, Inc. secured $500,000 in new convertible debt, part of a larger $2.65 million financing series, providing crucial capital amidst severe financial distress and a going concern warning.


Key Events · Financing and Capital Events · SURG

  • New Secured Convertible Note

    SurgePays, Inc. entered into a secured note purchase agreement for a $500,000 promissory note, effective June 16, 2026.

  • Part of Larger Financing Series

    This note is the most recent tranche in a series of financings that began in January 2026, bringing the aggregate funding received to $2,650,000.

  • High Conversion Prices and Interest Rate

    The note accrues interest at 14.5% per annum and is convertible into common stock at escalating prices ranging from $2.00 to $10.00 per share, significantly above the current stock price of $0.40.

  • Junior Security Interest Granted

    The investor receives a junior security interest in all company assets, with Belleau Wood Capital LP appointed as the collateral agent.


Analysis · SURG · Technology

SurgePays, Inc. has secured an additional $500,000 through a new secured promissory note, bringing the total raised in this financing series to $2.65 million since January 2026. This capital infusion is critical for the company, which recently reported a Q1 net loss nearly matching its market capitalization and disclosed substantial doubt about its ability to continue as a going concern. The note carries a high 14.5% interest rate and grants a junior security interest, reflecting the company's precarious financial position. While dilutive if converted, the conversion prices are set significantly above the current stock price, indicating a long-term bet on a substantial recovery by the investor. The proceeds will be used for business development, general working capital, and repayment of certain senior indebtedness, providing a much-needed lifeline.

At the time of this filing, SURG was trading at $0.40 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.1M. The 52-week trading range was $0.40 to $3.45. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SURG - Latest Insights

SURG
Aug 06, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4003
Real-time Price: $0.3272 info
Change: -$0.0731 (-18%) info
Market Cap: $8.165M info
SURG
Jul 29, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.230
Real-time Price: $0.3272 info
Change: +$0.0972 (+42%) info
Market Cap: $8.165M info
SURG
Jul 01, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.6199
Real-time Price: $0.3272 info
Change: -$0.2927 (-47%) info
Market Cap: $8.165M info
SURG
Jul 01, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4149
Real-time Price: $0.3272 info
Change: -$0.0877 (-21%) info
Market Cap: $8.165M info
SURG
Jun 22, 2026, 5:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4021
Real-time Price: $0.3272 info
Change: -$0.0749 (-19%) info
Market Cap: $8.165M info